Theraflu Extra Lemon 650mg+10mg+20mg powder for oral solution with lemon flavour

Pays: Arménie

Langue: anglais

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Ingrédients actifs:

paracetamol, phenylephrine (phenylephrine hydrochloride), pheniramine (pheniramine maleate)

Disponible depuis:

Famar Orleans

Code ATC:

N02BE51

DCI (Dénomination commune internationale):

paracetamol, phenylephrine (phenylephrine hydrochloride), pheniramine (pheniramine maleate)

Dosage:

650mg+10mg+20mg

forme pharmaceutique:

powder for oral solution with lemon flavour

Unités en paquet:

(10) sachets 15g

Type d'ordonnance:

OTC

Statut de autorisation:

Registered

Date de l'autorisation:

2019-06-05

Résumé des caractéristiques du produit

N O V A R T I S
Global Drug Regulatory Affairs
THERAFLU EXTRA LEMON
Powder in Sachets
Actives substances
Paracetamol 650mg; Pheniramine maleate 20mg;
Phenylephrine hydrochloride 10mg;
SUMMARY OF PRODUCT CHARACTERISTICS
Property of Novartis Consumer Health
SA Confidential
May not be used, divulged, published or otherwise
disclosed without the consent of Novartis Consumer Health
SA
TABLE OF CONTENTS
1.
NAME OF THE MEDICINAL PRODUCT
.........................................................................
3
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
.............................................. 3
3.
PHARMACEUTICAL FORM
..............................................................................................
3
4.
CLINICAL PARTICULARS
.................................................................................................
3
4.1 THERAPEUTIC INDICATIONS
................................................................................................
3
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
................................................................... 3
4.3.
CONTRAINDICATIONS
.......................................................................................................
3
4.4.
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
.................................................... 4
4.5.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION ......... 4
4.6.
PREGNANCY AND LACTATION
.............................................................................................
5
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
............................................................ 5
4.8.
UNDESIRABLE EFFECTS
.......................................................................................................6
4.9.
OVERDOSE
.......................................................................................................................
6
5.
PHARMACOLOGICAL PROPERTIES
..............................................................................
7
5.1.
PHARMACODYNA